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The diagnosis of bacterial endocarditis remains a challenge, as nearly half of cases develop in the absence of preexistent heart
disease and known risk factors. Not infrequently, a blunted clinical course at onset can lead to erroneous diagnoses. We present
the case of a 47-year-old previously healthy man in which a presumptive diagnosis of antiphospholipid syndrome was made based
on the absence of echocardiographically detected heart involvement, a negative blood culture, normal C-reactive protein (CRP)
levels, a positive lupus anticoagulant (LAC) test, and evidence of splenic infarcts. The patient eventually developed massive aortic
endocarditic involvement, with blood cultures positive for Streptococcus bovis, and was referred for valvular replacement. This case
not only reminds us of the diagnostic challenges of bacterial endocarditis, but also underlines the need for a critical application of
antiphospholipid syndrome diagnostic criteria.
1. Introduction
Antiphospholipid syndrome (APS) and infective endocardi-
tis (IE) are diﬃcult-to-diagnose diseases and share several
clinical features. To increase the probability of excluding
temporary infection-associated antibodies, current diagnos-
tic criteria for APS require Antiphospholipid Antibodies
(APA) positivity on two separate occasions at least twelve
weeks apart [1]. We describe here the case of a 47-year-
old male in whom an erroneous diagnosis of presumptive
APS, waiting for confirmatory laboratory test, was made,
leading to a potentially dangerous delay in the treatment of
infective endocarditis. The diagnostic challenges presented
by this patient are discussed.
2. Case Report
A 47-year-old previously healthy man was admitted to
our department because of arthralgias, remittent fever, and
pericardial eﬀusion. His medical history was unremarkable.
Approximately one year earlier he had had an episode of
paroxysmal atrial fibrillation with pharmacological resto-
ration of sinus rhythm. For the past six months before
admission, he reported remittent low-grade fever, tachycar-
dia, night sweats, cervical pain, and migratory arthralgias
with transient joint swelling. The patient was evaluated by
an internal medicine specialist. Blood test revealed WBC
7.000/mmc, Hb 14.0 g/dL, and C-reactive protein (CRP)
9.3mg/L. C3 and C4 complement components were within
normal limits, and antinuclear antibodies were absent.
A small IgG-K monoclonal gammopathy (7.94 g/L) was
detected, with negative Bence-Jones proteinuria. A blood
culture was negative. Silica clotting time, lupus anticoagulant
(LAC) screening (LAR 1.97), and confirmatory tests (LAR
1.32) were positive. Nomurmur was found on cardiac exam-
ination. An electrocardiogram showed normal sinus rhythm,
and at transthoracic echocardiogram (TTE), only trivial
tricuspidal and aortic regurgitation was found. Routine chest
X-ray was unremarkable, but a chest and abdomen CT scan
showed tiny bilateral pleural eﬀusions and an enlarged spleen
with small parenchymal infarctions.
At rheumatological consultation, a confirmatory LAC
test was positive. Anticardiolipin (aCL) and anti-β2 gly-
coprotein-I antibodies were absent. Screening tests for
associated thrombophilic risk factors revealed the presence
of MTHFR 677/CT mutation with hyperhomocysteinemia
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(19.1 μmol/L). A preliminary diagnosis of APS, waiting for
confirmatory LAC test over 12 weeks [1], was made, and
treatment with acetylsalicylic acid 100mg/day and etoricoxib
90mg/day as needed, along with folic acid and vitamin B6
supplementation, was instituted, resulting in remission of
arthralgias and amelioration of general well-being. Remitting
fever sometimes with shivering persisted throughout the
subsequent weeks. Three weeks later, he was admitted to
an emergency department complaining of tachycardia and
dyspnea. Body temperature was 38.5◦C, heart rate was
105 bpm, and respiratory rate was 28/min. Blood pressure
was 110/65mmHg, and oxygen saturation was 96% while
the patient was breathing ambient air; the remainder of
the examination was normal. Inflammatory markers were
slightly elevated. An echocardiogram was performed, show-
ing only moderate pericardial eﬀusion. Pleural fluid analysis
showed absence of neoplastic cells and a leucocyte count
lower than 250/mmc, and cultures were negative. Laboratory
data showed a positive c-ANCA test (30U/mL). IgM aCL
antibodies were positive (64MPL). LAC was not retested.
The clinical picture was interpreted as an autoimmune
pleuropericarditis, and treatment with aspirin 3 g daily and
methylprednisolone (1mg/kg/day) was instituted.
At the time of admission to our department, 20 days
later, the patient had remittent fever with daily spikes over
38.5◦C. The pulse rate was 140 bpm, blood pressure was
120/85mmHg, and respiratory rate was 24/min. Oxygen
saturation was 94% while the patient was breathing ambient
air. Acute-phase reactants were significantly increased
(CRP= 83.3mg/L). Blood and urine chemistries were oth-
erwise within normal ranges. aCL and ANCA were absent.
On physical examination, the patient appeared asthenic but
not acutely ill. There was no cervical lymphadenopathy.
The lower liver edge was palpated 2 to 3 cm below the right
costal margin. Auscultation of the chest revealed bibasilar
rales. There was a grade 3/6 systolic murmur and a grade
2/6 protodiastolic murmur. An electrocardiogram showed
normal sinus rhythm with only nonspecific repolarization
abnormalities. A transthoracic echocardiogram revealed a
moderate-to-severe jet of aortic regurgitation (Figure 1),
and three floating structures adherent to the aortic
cusps, of which the greatest was 30 × 10mm, were
visualized (Figure 2). Moderate to severe mitral insuﬃciency
due to annular dilation without significant mitral valve
leaflets involvement was present, and moderate tricuspidal
insuﬃciency with pulmonary hypertension (pulmonary
artery pressure: 60mmHg) was observed. Transesophageal
echocardiogram confirmed the findings of the transthoracic
examen, showing a large vegetation originating from the
ventricular side of semilunar valves and protruding into
the left ventricle during diastole. The patient was eventually
referred to the heart surgery division. Intraoperatively,
endocarditis aﬀecting the ventricular side of the three aortic
cusps and without annular involvement was confirmed.
Aortic valve replacement and mitral valve ring annuloplasty
were performed. Pleuritic (1800ml) and pericardial
eﬀusions were removed. Blood cultures were positive for
Streptococcus bovis, and the patient was treated with Gen-
tamicin 240mg/day and Ampicillin 12 gr/day, and long-term
P
Figure 1: Color doppler evaluation of the aortic valve regurgitation:
the arrow points to “vena contracta” of a central severe regurgitant
jet.
anticoagulation with warfarin was started. Finally, a
colonoscopy was performed, as the association between
S. bovis bacteremia or endocarditis and colonic neoplasia has
been appreciated for many years, and a small adenomatous
polyp was retrieved in the ascending colon.
The patient had an uneventful postoperative recovery,
with rapid return to his usual activities. At a follow-up visit,
six months later, the patient was asymptomatic, all autoanti-
bodies tested were negative, and LAC test was negative.
3. Discussion
IE remains a diagnostic challenge [2]. Up to 47 % of IE cases
develop in patients without previously known heart disease
[3] and in the absence of known risk factors. While early
diagnosis greatly decreases complications and increases the
chance of recovery, IE may present as a subacute or chronic
disease with low-grade fever and nonspecific symptoms
which may confuse the initial assessment and suggest a
range of alternative diagnoses including rheumatologic and
autoimmune diseases. In particular, S. bovis IE, which
seems to be increasing in frequency [4], is characterized by
subacute clinical features. 72% of patients with IE due to
this organism do not have previously known cardiac valvular
abnormalities. S. bovis is also associated with spondylitis
(9%) and colonic tumors (53%) [4, 5]. Antiphospholipid
syndrome [6] shares many clinical features with IE, including
vascular thrombotic events, endocardial vegetations, and
renal and cutaneous involvement. Valvular involvement,
most often aﬀecting the mitral valve, is very frequent in both
primary APS [7] and in SLE-associated APS [8]. In primary
APS, valvular disease was reported in 30% to 40% of patients
by transthoracic echocardiography (TTE), and in 60% to
80% of patients by transesophageal echocardiography (TOE)
[9]. Focal or diﬀuse leaflet thickening and small nodules were
most commonly observed, and the presence and extent of
valvular vegetations were associated with APA titers [7, 8].
According to the revised Sapporo criteria, the diagnosis
of APS relies on the presence of clinical (vascular thrombosis
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Figure 2: Transthoracic echocardiographic examination: parasternal long axis view. The arrows indicate two vegetations on the ventricular
side of the aortic valve cusps (right and noncoronary).
or pregnancy morbidity) and laboratory criteria (presence of
antiphospholipid antibodies) [1]. However, the diﬀerential
diagnosis between IE and APS in individual cases may
be diﬃcult, as antiphospholipid antibodies are frequently
positive during infections [10]. On the other hand, fever
can be present in antiphospholipid syndrome, and cases of
APS presenting as fever of unknown origin [11] or truly
mimicking IE—the so-called pseudoinfective endocarditis
[12]—have been described. Furthermore, APS-related valvu-
lar lesions may serve as a substrate for bacterial colonization
[12].
The initial presentation of our patient was consistent
with the diagnosis of APS, based on the presence of
lupus anticoagulant, and the evidence of splenic infarcts.
Leucocytosis was absent, and PCR was not raised, further
suggesting a noninfectious process. The correct diagnosis
was eventually made only two months later, after a high-
dose corticosteroid course which might have contributed to
the rapid growth of aortic vegetations, thus increasing the
embolic risk of the patient [10]. However, a high degree
of suspicion and strict adherence to diagnostic algorithms
could have led to the correct diagnosis. In our case, the
presence of fever with systemic symptoms (poor appetite,
weight loss, chills), with evidence of embolism should have
strengthened the suspicion of IE [2]. The modified Duke
criteria are currently largely applied to the diagnosis of
IE [13]: the sensitivity of the modified Duke criteria is
estimated to be around 100%, with a specificity of 80% and
a PPV of 100% [14]. Echocardiogram and blood cultures
are the cornerstones of diagnosis and are the major criteria
for the diagnosis according to Duke criteria. Both were
negative in our case. However, only 1 blood culture was
performed, instead of the 3 recommended by guidelines
[2]. Furthermore, TTE identifies only 25% of vegetations
<5mm on native valves and 70% of vegetations >6mm.
Overall, the sensitivity of TTE on native valves is 65% while
the sensitivity of TOE reaches 85 to 95%. The specificity is
higher when both methods are used (90–98%) [15]. The
first echocardiogram may not be suﬃcient for diagnostic
purposes, and if clinical suspicion is high, it is recommended
to perform TOE and to repeat TTE examinations at weekly
intervals [2]. Furthermore, it has been reported that TTE
is positive in only a minority of cases when, as in our case,
few clinical criteria are present [16], and recent data suggest
that TOE might be the investigation of choice in culture-
negative infective endocarditis [17]. In our case, TOE was not
performed for six months after the onset of symptoms.
A final point concerns the diagnosis of APS. As it has
been pointed out, the APS diagnostic criteria lack specificity
and have not been adequately tested in populations other
than systemic lupus erythematosus [18]. Undue reliance on
APS diagnostic criteria should be avoided when infectious
diseases, which can be associated with nonspecific antiphos-
pholipid antibodies production [7], are suspected.
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